|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1994-3-17
|
|
pubmed:abstractText |
The Monitored Atherosclerosis Regression Study (MARS) was designed to evaluate the effect of cholesterol lowering by monotherapy with an HMG-CoA reductase inhibitor on progression/regression of atherosclerosis in subjects with angiographically documented coronary artery disease. The purpose of this paper is to present the design, methods, and baseline results of MARS.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1059-2725
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
23
|
|
pubmed:volume |
Doc No 26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
[9897 words; 83 paragraphs]
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1343613-Adult,
pubmed-meshheading:1343613-Aged,
pubmed-meshheading:1343613-Cholesterol,
pubmed-meshheading:1343613-Cholesterol, Dietary,
pubmed-meshheading:1343613-Coronary Angiography,
pubmed-meshheading:1343613-Coronary Artery Disease,
pubmed-meshheading:1343613-Dietary Fats,
pubmed-meshheading:1343613-Double-Blind Method,
pubmed-meshheading:1343613-Female,
pubmed-meshheading:1343613-Humans,
pubmed-meshheading:1343613-Lipoproteins,
pubmed-meshheading:1343613-Lovastatin,
pubmed-meshheading:1343613-Male,
pubmed-meshheading:1343613-Middle Aged,
pubmed-meshheading:1343613-Prospective Studies,
pubmed-meshheading:1343613-Remission Induction,
pubmed-meshheading:1343613-Treatment Outcome,
pubmed-meshheading:1343613-Triglycerides
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
|
|
pubmed:affiliation |
Atherosclerosis Research Institute, University of Southern California School of Medicine, Los Angeles 90033.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
